-
22 September 2021
Introducing the New and Improved Keeogo+TM
Québec City (Quebec) September 22, 2021 – B-Temia Inc. is proud to announce the launch of a brand-new version of its flagship product, Keeogo. […]
-
17 June 2021
B-TEMIA ASIA OBTAINS TAIWAN FOOD & DRUG ADMINISTRATION (TFDA) PRODUCT LICENSE
Québec City, QC, September 21, 2020 – B-Temia Asia, a joint venture company between Wistron Medical Technology Company and B-Temia Inc. (the “Company”) incorporated in […]
-
21 September 2020
B-TEMIA INC. OBTAINS 510(K) CLEARANCE FOR KEEOGO™ FROM THE USA FOOD & DRUG ADMINISTRATION (FDA)
Québec City, QC, September 14, 2020 – B-Temia Inc. (the “Company”) announces that it received 510(k) clearance from the United States Food and Drug Administration […]
-
10 December 2019
B-TEMIA’S KEEOGO TM OBTAINS CE MARKING ALLOWING ITS COMMERCIALIZATION IN EU COUNTRIES
Québec City, QC, December 10, 2019 – B-Temia Inc. (the “Company”), a Canadian robotics tech company and leader in the human mobility market, announces today that it […]
-
29 November 2018
CANADIAN TECH COMPANY B-TEMIA ENTERS INTO A $6.9M USD US ARMY / LOCKHEED MARTIN AGREEMENT
B-Temia and Lockheed Martin Team Up to Optimize ONYXTM Exoskeleton Québec City, QC | On November 29, 2018, B-Temia, a Canadian robotics tech company and […]
-
28 November 2018
B-TEMIA AND WISTRON ANNOUNCE THE INCORPORATION OF B-TEMIA ASIA
B-Temia Asia will launch human mobility device Keeogo™ in the Asia Market Québec City, QC, November 27, 2018 – B-Temia Inc. today announced the official incorporation of […]